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Human molecular chronotyping in sight?
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Abstract
Recent research on mouse models has taken us closer to deciphering the molecular clock
mechanism that defines an individual’s ‘body time’. How feasible will it be to create a molecular
timetable that allows determination of individual body time from tissue harvested at a single
time point? 
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All human beings have in common the characteristic of
going to sleep at night and waking up in the morning auto-
matically. As we stumble into a new day, the body prepares
itself for the new tasks ahead and increases heart rate, blood
pressure and temperature; conversely, these parameters
decrease in the evening. Such daily occurring rhythms with a
period of about 24 hours are termed circadian rhythms,
because they manifest themselves even under constant con-
ditions - that is, even in the absence of stimuli that recur
with a 24 hour periodicity, such as daylight. The length of
the circadian period is relatively unaffected by changes in
temperature or nutritional state. Its phase, however, can be
synchronized, or ‘entrained’, to the environment by light,
food or temperature.
It is thought that the circadian timing system provides a
benefit to the organism by providing a temporal structure
across the body so as to modulate and synchronize biological
function and to prevent activation of biochemical pathways
that have adverse effects on each other. During the day cata-
bolic processes facilitate engagement with the environment,
whereas at night anabolic functions of growth, repair and
consolidation predominate (reviewed in [1]). It is evident
that medical treatment elicits responses from the body that
are dependent on its internal time. Hence, medical treat-
ment can have adverse effects on the patient when it is given
at the ‘wrong’ hour of the day [2,3]. This makes it essential to
determine body time if we are to maximize the benefits of
medical treatment. It is of great interest to understand how
the circadian clock works at the molecular level and how to
use this information to generate a molecular timetable that
allows profiling of an individual’s biochemical pathways in
time. Over the past few years significant progress towards
this end has been made using animal models. In this article I
briefly describe the molecular mechanism of the clock in
mammals and then discuss a microarray-based method, pro-
posed by Ueda et al. [4] for determining body time.
The molecular circadian oscillator and some of
its targets 
The molecular mechanism of the circadian clock has been
unraveled by means of genetic analysis in Drosophila and
mammals (reviewed in [5], see Figure 1). This mechanism
seems also to be applicable to humans. An autosomal domi-
nant mutation in the human Per2 gene that inactivates a
binding site for casein kinase I   (CKI ) results in familial
advanced sleep phase syndrome (FASPS) [6]. Because
hypophosphorylated Per proteins seem to have a higher
metabolic stability than their hyperphosphorylated counter-
parts, the mutant protein accumulates and the threshold
levels of Per complexes required for feedback repression are
reached faster than in individuals without the mutation. As a
consequence, the period length of the circadian clock short-
ens and hence, the inner wake-up call of FASPS patients is
advanced and falls in the early morning hours. It should be
pointed out that the mechanism illustrated in Figure 1 repre-
sents a working hypothesis, because many issues remainunanswered in this simplified scheme. For example the
phase of Rev-erb  expression should be in phase with the
expression of Per and Cry genes according to the model, but
in fact its mRNA accumulation peak differs from theirs by
about 9-11 hours. 
The genes involved in the molecular feedback-loop described
in Figure 1 could be viewed as analogous to the cogwheels of
a wristwatch. Without hands such a clock would not be of
great use. Similarly, the circadian clock must somehow
interact with biochemical pathways that produce physiologi-
cal circadian rhythms in the organism. The obvious assump-
tion is that some of the molecular clock components interact
or activate genes involved in the relevant biochemical path-
ways. The search for E-box enhancer elements in the pro-
moters of potentially important proteins, and examination of
their transcriptional regulation by Clock and Bmal1, has led
to the identification of several clock-controlled genes.
Among these are the arginine vasopressin gene (Avp), D-
element-binding protein (Dbp), type 1 adenylyl cyclase (AC1)
and the cell-cycle regulator wee1. Of note is that Dbp can reg-
ulate expression of members of the cytochrome P450 family,
such as cholesterol 7 -hydroxylase, and can impose a circa-
dian activation pattern on these genes as a result of its own
circadian regulation by Clock/Bmal1 [7]. Hence, such genes
are regulated indirectly by Clock/Bmal1 via Dbp. A change in
clock parameters will therefore not affect all circadian-
expressed genes in the same manner, and this complicates
the idea of creating a unifying time-course gene-expression
map for different individuals within a population. 
Determination of body time: chronotyping 
Although the human body is regulated by a complex network
of processes ordered along the timeline of a 24 hour day, the
phase of the 24 hour oscillations can vary between individu-
als, as is evident from the observation that in every society
we find some individuals behaving as larks and others as
owls. This poses a problem for generalized medicine.
Whereas a specific medical treatment schedule can have
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Figure 1
A simplified model of the mammalian circadian clock mechanism. Bmal1 and Clock proteins bind at E-box enhancer elements present in the promoters of
Ror , Rev-Erb , Cry and Per genes and drive their expression in the nucleus. Complexes of Per and Cry proteins in the nucleus inhibit Clock/Bmal1 action
by an unknown mechanism, thereby down-regulating their own expression and that of Ror  and Rev-Erb . Absence of Rev-Erb  protein derepresses
Bmal1 and possibly also Clock, and their proteins reinitiate a new circadian cycle. How the timing between Rev-Erb  and ROR  proteins is established is
not understood. An essential feature of the clock is posttranslational modification. Casein kinase I (CKI)   and   isoforms phosphorylate Per, Cry and
Bmal1 proteins, decreasing their stability and therefore critically regulating the time of action of clock proteins. Periodic gene expression is indicted by a
single wave.
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Clock Bmal1positive effects for a ‘lark’ type of person, the very same
therapy can have negative consequences for an ‘owl’ type of
person [8]. This is not only an anecdotal issue: it is demon-
strated by the finding that altering the timing of chemother-
apy increases its efficiency [2]. To tailor the timing for a
therapy such as chemotherapy for a single human being, it is
of interest to determine the phase of the clock in the body
relative to a reference time, such as the mean of the popula-
tion’s clock phase. Hence, an individual’s internal body time
reveals the chronotype (lark or owl) of that person. When
referring to timings within the diurnal cycle of an individu-
al’s clock, researchers use the concept of zeitgeber time (ZT),
in which ZT is 0 at the beginning of the light phase (day). 
An elegant method for chronotyping individual mice has
been proposed by Ueda et al., [4]. Their method is based on
a molecular timetable composed of a selection of genes that
are supposed to indicate time. It is evident from the descrip-
tion of the molecular clock mechanism in Figure 1 that not
all genes are similarly suited to being part of such a
timetable. To select suitable genes Ueda et al. [4] applied
two selection criteria for candidate genes analyzed using
Affimetrix murine genome microarrays: circadian rhythmic-
ity and high amplitude expression. Genes meeting these cri-
teria were selected and assigned to a group according to the
time of their maximal expression on the 24 hour scale. For
example, a gene with maximal expression at ZT=0 is
described as having a molecular peak time (MPT) of 0, while
a gene with maximal expression at ZT=4 has an MPT of 4,
and so on. Combining all these expression profiles gives a
graph like that in Figure 2a. This molecular timetable allows
us to define a relative body time given that all the genes in
this timetable are normalized for similar maximal expres-
sion. For example, if we isolate tissue of an individual mouse
at ZT=12 and determine the expression level of the genes
selected for the molecular timetable (boxed in Figure 2a) we
can represent the expression level of these genes as a func-
tion of their MPT (Figure 2b). If for all MPTs similar
numbers of genes are present in the molecular timetable, a
cosine curve can be fitted through the data points (Figure
2b) and an MPT curve is generated. The same procedure
can be done with tissue isolated at other times (such as
ZT=0, ZT=4 and ZT= 6). This illustrates that gene expres-
sion of a single tissue sample taken at a specific time can be
visualized and can reveal temporal information. If this
information is now compared to a standard cosine curve
derived from the same tissue of a large number of individu-
als, deviations of an individual’s MPT curve from the stan-
dard MPT can be derived (in Figure 2c an example of tissue
collection at ZT=12 is shown). The peak of the standard
MPT defines standard body time (BTS), which is 12 for a
tissue collected at ZT=12. If the MPT curve derived from an
individual deviates from the standard MPT, this individual’s
body time is not ZT=12; as illustrated in Figure 2c, this is
ZT=10 for individual 1 (BT1) or ZT=14.5 for individual 2
(BT2). If the difference in BT compared to the standard BT is
larger than the error, the shift in internal timing of the body
compared to a standard can be considered ‘real’.
This method does not only allow determination of individual
body time, it is also useful to reveal gross alterations in the
functioning of the circadian clock. Ueda et al. [4] demon-
strated this for mice mutant for the Clock gene. The expres-
sion levels of the genes from the molecular timetable plotted
as a function of the MPT are scattered and no cosine curve
can be fitted through the data points (Figure 2d), indicating
a disrupted clock mechanism. This is consistent with the loss
of circadian wheel-running behavior in constant darkness
that is observed in these mice [9].
It appears that this method opens enormous possibilities for
individual chronotyping, but for the moment we have to
view this approach with a grain of salt. First, Ueda et al. [4]
have shown the feasibility of this method in mice, where
tissue is easily accessible and large quantities can be used for
experimentation; will it work for humans? Second, the
choice of tissue seems to be important. As revealed by a
number of microarray studies, most tissues display phase-
specific patterns of clock and clock-controlled gene expres-
sion (reviewed in [10]). For example in the heart most of the
circadian-expressed genes peak around ZT=2 [11], whereas
in fibroblast cells ZT=6 and ZT=22 are the most frequently
observed peak times [12]. This makes it more difficult to
select genes suitable for the molecular timetable, because it
is important that the genes evaluated are evenly represented
over time so that the cosine curve fitting is not biased
towards a specific group of genes over-representing an MPT.
Ueda et al. [4] used liver tissue in their proof-of-principle
experiment, and this is the tissue with the most homogenous
distribution of MPTs of different genes. But, they also
applied the molecular timetable method to brain tissue and
in particular to tissue from the suprachiasmatic nucleus
(SCN), a structure in the ventral part of the hypothalamus
that contains a circadian clock that can coordinate the clocks
found in other tissues. MPTs in the SCN are not evenly dis-
tributed, but are clustered at dawn (ZT=22) and dusk
(ZT=10) [13]. This clustering can also be seen in the data for
SCN tissue provided by Ueda et al. [4] (in their supplemen-
tal Figure 8). In the cosine curve fitting, MPT 0 and MPT 14
are strongly under-represented, leading to a larger error in
cosine curve fitting and hence the method is less precise for
SCN tissue than for liver.
It is evident that the reliability of the molecular timetable
method depends crucially on the genes selected. One would
expect that the clock components shown in Figure 1 are good
candidates to be part of that timetable. But, comparing these
genes with the table constructed by Ueda et al. [4] for mouse
liver (162 genes) and mouse SCN (96 genes), only Per2 and
Cry1 are included in the liver timetable, whereas Per1, Per2,
Cry1, Ror  and Dbp are included in the SCN timetable. The
reason for the higher representation of clock genes in the
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that peak at times other than those of the main clock compo-
nents shown in Figure 1. Their maximal expression is
observed at ZT=6-8 (Per1), ZT=8-12 (Per2), ZT=12 (Cry1),
ZT=6 (Ror ) and ZT=12 (Dbp). In the liver, however, a large
number of metabolic enzymes are part of the timetable,
including alcohol dehydrogenase, several enzymes of the
cytochrome P450 family, aminolaevulinate synthase 1, fatty
acid synthase and hydroxymethylglutaryl-CoA synthase 1.
Some of these genes are indirectly regulated by the clock (as
discussed above), which might be a reason for a more even
distribution of MPTs in the liver timetable. It is nevertheless
astonishing that more clock genes are not included. One
interpretation of this finding could be that transcription
factors other than those shown in Figure 1 play a major role
in driving clock gene expression in the liver. This idea is sup-
ported by the observation that several uncharacterized genes
are part of the liver timetable.
In summary Ueda et al. [4] have demonstrated that the mol-
ecular timetable method is applicable for mice. Even in a
mouse strain with a heterogenous genetic background the
method allows the estimation of body time, albeit with less
precision than in mice of homogenous genetic background.
The greatest challenge for the future will be in tailoring the
method for humans. Tissue collection will be a major con-
straint, given that it is practically not possible to get liver
tissue (the best suited for the analysis) nor SCN tissue from
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Figure 2
The molecular timetable method of Ueda et al. [4]. (a) The expression of genes that oscillate in a 24 hour fashion is characterized by their molecular
peak time (MPT). Schematized genes with specific circadian patterns of expression are represented by different symbols. An overlay of all oscillating
expression patterns should ideally render an even distribution of maximal gene expression over the 24 hour day. Note that the diagram is double plotted
and displays two days (48 hours). This molecular timetable can be used to generate a diagram of MPT distribution at a single time point, such as ZT=12
(boxed). (b) Representation of the MPT at a single time point with a fitted cosine curve at ZT=12; genes with MPTs of 12 are maximally expressed.
(c) A schematic diagram for detecting body time (BT). A standard cosine curve (solid line) for tissue harvested at ZT=12 is shown. The maximal
normalized expression level indicates standard BT (BTS). The cosine curve of tissue collected at ZT=12 of individual 1 (dotted line) reveals a BT1 about 2
hours earlier than BTS. Individual 2 displays a delayed cosine curve (hatched line, BT2). (d) A plot of normalized gene expression of a clock-mutant
individual. The scattered distribution does not allow fitting of a cosine curve.
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(c) (d)humans. More easily accessible tissues, such as buccal tissue
or skin fibroblasts, must therefore be considered. The next
step will be to select suitable genes in these tissues repre-
senting the whole 24 hours of a day in the heterogenous
human population. Large numbers must be analyzed, so as
to establish a standard to which individual samples can be
compared. A complementary approach to body time estima-
tion would be determination of an individual’s clock period
by culturing their fibroblasts. Because clock oscillation can
be monitored in single cells [14] using marker genes indi-
cated in Figure 1, the period length of an individual’s clock
can be derived. The phase of the clock relative to a standard -
that is, the individual body time - can not be determined
with this method, however. Real-time PCR offers another
possibility not only for determining the clock period but also
body time. Compared to the molecular timetable method, a
PCR-based method for amplifying a few clock genes would
need several tissue samples taken at different times. For
example, buccal swabs taken every two to three hours from
an individual would be suitable for constructing an individual’s
circadian expression curve for a particular clock gene. For all
such methods a common crucial factor is standardization of
tissue sampling. Human clock phase is strongly influenced
not only by illumination, temperature and social factors but
also, for example, by exercise [15]. To gain reproducible and
comparable results external factors have to be excluded
using constant routine protocols [16,17]: a person will have
to be in isolation for a period of time. This illustrates the
huge effort that will have to be made if we are to achieve
precise individual chronotyping. But we can hope that char-
acterization of human chronotypes using gene-expression-
based methods will facilitate diagnosis of circadian rhythm
disorders and might support the development of
chronotherapy and personalized medicine, as long as the
above-mentioned difficulties can be overcome.
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